Skip to content

About PSM

HHS comments come in overwhelmingly against Canadian drug importation proposal

Yesterday ended a 78-day comment period for the White House’s proposal to import medicine from Canada. In all, over 1,000 comments were filed. Overwhelmingly, these comments opposed the proposed rule or expressed skepticism that the rule could meet the two requirements listed in the Medicare Modernization Act of 2003: be safe and save consumers money. In fact, when you read the comments, it is clear that this policy is overwhelming opposed by experts on the issues of economics and medicine safety.

[...]

Canadian Importation Does Not Work

graph comparing the population of Canada to the US

The number of U.S. residents in states that are considering importing drugs from Canada is almost four times Canada’s own population. Canadian drug importation is not the structural solution we need.

[...]

“5 Ways” consumer bookmark

Download our “5 Ways” Consumer Bookmark for a quick reference about how to protect yourself from counterfeit medicine.  

[...]

Policy Resolution, January 8, 2020

The following policy resolution was passed unanimously at the Jan. 8, 2020 board meeting in Washington DC. The governing board of the Partnership for Safe Medicines votes today to reiterate that the Partnership is organized to focus entirely of the safety of medicine as it travels through the supply chain, as we have since our…

[...]

Infographic: Counterfeiting By The Numbers

Our infographic, “Counterfeiting by the Numbers,” highlights facts from the U.S. Department of Homeland Security’s January 2020 report, Combating Trafficking in Counterfeit and Pirated Goods, which documents the extraordinary scale of the global counterfeiting market and its effects across all economic sectors—including medicines.

[...]

PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.

The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…

[...]

HHS Announces Dangerous Draft Regulations for Importing Drugs from Canada

Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…

[...]
Scroll To Top